Research Square·20 AugMulti-dimensional attention framework for personalised Alzheimer's disease progression prediction across sporadic and genetic risk cohortsPreprint: computational studyBiomarkersPaper
AAIC 2025 Abstract·9 JanAPOE ε4 Does not increase rate of amyloid accumulation or tau phosphorylation in adults with Down SyndromeStudy in peoplePopulationsPaper
AAIC 2025 Abstract·9 JanLongitudinal associations of intra‐individual cognitive variability with dementia, cognitive change and PET amyloid‐ß in adults with Down syndrome: data from the Alzheimer's Biomarker Consortium‐ Down Syndrome (ABC‐DS)Study in peopleBiomarkersPaper
AAIC 2025 Abstract·8 JanRegional tau burden emerges following beta‐amyloid chronicity timeline in the Down syndrome populationStudy in peopleMechanismsPaper
GSA 2025 Abstract·3 JanLife Stress and Dementia Risk in Adults with Down SyndromeStudy in peoplePopulationsPaper
AAIC 2025 Abstract·26 DecFactors Associated with Atypical Cognitive Trajectories in Older Adults with Down SyndromeStudy in peoplePopulationsPaper
AAIC 2025 Abstract·26 DecCorrelating antemortem amyloid PET burden, postmortem MRI volumes, with neuropathological measures: Insights from Down syndrome and Alzheimer's disease cohortsStudy in peopleMechanismsPaper
AAIC 2025 Abstract·25 DecPlasma pTau217 as a marker of both the current and future state of amyloid pathology in adults with DSStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecPrediction of future tau accumulation and cognitive decline in Down Syndrome using plasma biomarkersStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecRegional tau burden emerges following beta‐amyloid chronicity timeline in the Down syndrome populationStudy in peopleMechanismsPaper